Karsten H. Weylandt

4.1k total citations · 1 hit paper
71 papers, 3.2k citations indexed

About

Karsten H. Weylandt is a scholar working on Nutrition and Dietetics, Biochemistry and Surgery. According to data from OpenAlex, Karsten H. Weylandt has authored 71 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Nutrition and Dietetics, 33 papers in Biochemistry and 15 papers in Surgery. Recurrent topics in Karsten H. Weylandt's work include Fatty Acid Research and Health (39 papers), Eicosanoids and Hypertension Pharmacology (33 papers) and Liver Disease Diagnosis and Treatment (10 papers). Karsten H. Weylandt is often cited by papers focused on Fatty Acid Research and Health (39 papers), Eicosanoids and Hypertension Pharmacology (33 papers) and Liver Disease Diagnosis and Treatment (10 papers). Karsten H. Weylandt collaborates with scholars based in Germany, United States and United Kingdom. Karsten H. Weylandt's co-authors include Jing X. Kang, Bertram Wiedenmann, Cheng‐Ying Chiu, Wolf‐Hagen Schunck, Michael Rothe, Jingdong Wang, Robert Fischer, Anne Konkel, Axel Dignaß and Christopher F. Higgins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Karsten H. Weylandt

68 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?

2022 118 citations Nils Helge Schebb, Hartmut Kühn et al. Frontiers in Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karsten H. Weylandt Germany	30	1.4k	970	962	553	452	71	3.2k
Paul C. Norris United States	30	1.2k 0.8×	1.2k 1.3×	1.1k 1.1×	423 0.8×	387 0.9×	46	3.6k
Yang‐Yi Fan United States	29	1.1k 0.8×	1.1k 1.2×	583 0.6×	335 0.6×	434 1.0×	49	2.6k
Katherine Gotlinger United States	30	1.9k 1.3×	1.1k 1.1×	1.8k 1.9×	601 1.1×	557 1.2×	46	4.2k
Peter Zahradka Canada	35	909 0.6×	1.6k 1.7×	385 0.4×	818 1.5×	469 1.0×	182	4.0k
Harini Sampath United States	27	812 0.6×	1.9k 1.9×	637 0.7×	925 1.7×	539 1.2×	59	3.7k
Ondřej Kuda Czechia	34	1.1k 0.8×	1.5k 1.6×	617 0.6×	1.5k 2.8×	384 0.8×	95	3.7k
Aziz Hichami France	36	1.1k 0.8×	1.2k 1.2×	254 0.3×	496 0.9×	405 0.9×	111	4.0k
Esther Titos Spain	37	1.3k 0.9×	1.1k 1.1×	1.1k 1.1×	871 1.6×	531 1.2×	67	4.1k
Wendell J. Lu United States	10	991 0.7×	1.3k 1.3×	477 0.5×	1.1k 1.9×	660 1.5×	11	3.2k
Pamela M. Martin United States	40	415 0.3×	2.7k 2.8×	406 0.4×	777 1.4×	334 0.7×	95	4.7k

Countries citing papers authored by Karsten H. Weylandt

Since Specialization

Citations

This map shows the geographic impact of Karsten H. Weylandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karsten H. Weylandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karsten H. Weylandt more than expected).

Fields of papers citing papers by Karsten H. Weylandt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karsten H. Weylandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karsten H. Weylandt. The network helps show where Karsten H. Weylandt may publish in the future.

Co-authorship network of co-authors of Karsten H. Weylandt

This figure shows the co-authorship network connecting the top 25 collaborators of Karsten H. Weylandt. A scholar is included among the top collaborators of Karsten H. Weylandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karsten H. Weylandt. Karsten H. Weylandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hage, Racha El, Ruirui Wang, Yifang Chen, et al.. (2024). Harnessing Oxylipins and Inflammation Modulation for Prevention and Treatment of Colorectal Cancer. International Journal of Molecular Sciences. 25(10). 5408–5408. 4 indexed citations

Rohwer, Nadine, et al.. (2024). An Optimized Ex Vivo n –3 PUFA Supplementation Strategy for Primary Human Macrophages Shows That DHA Suppresses Prostaglandin E2 Formation. Molecular Nutrition & Food Research. 69(1). e202400716–e202400716. 2 indexed citations

Chen, Yifang, et al.. (2024). Circulating Omega-3 Polyunsaturated Fatty Acids Levels in Coronary Heart Disease: Pooled Analysis of 36 Observational Studies. Nutrients. 16(11). 1610–1610. 6 indexed citations

Zouboulis, Christos C., et al.. (2023). Effects of Moringa oleifera Seed Oil on Cultured Human Sebocytes In Vitro and Comparison with Other Oil Types. International Journal of Molecular Sciences. 24(12). 10332–10332. 10 indexed citations

Zhang, Qifang, et al.. (2022). The effects of omega-3 fatty acids in type 2 diabetes: A systematic review and meta-analysis. Prostaglandins Leukotrienes and Essential Fatty Acids. 182. 102456–102456. 32 indexed citations

Schebb, Nils Helge, Hartmut Kühn, Astrid S. Kahnt, et al.. (2022). Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?. Frontiers in Pharmacology. 13. 838782–838782. 118 indexed citations breakdown →

Zhang, Ingrid W., et al.. (2020). Assessment of the Effect of Sorafenib on Omega-6 and Omega-3 Epoxyeicosanoid Formation in Patients with Hepatocellular Carcinoma. International Journal of Molecular Sciences. 21(5). 1875–1875. 19 indexed citations

Schunck, Wolf‐Hagen, Michael Rothe, Birgit Rudolph, et al.. (2020). Regulation of the cytochrome P450 epoxyeicosanoid pathway is associated with distinct histologic features in pediatric non-alcoholic fatty liver disease. Prostaglandins Leukotrienes and Essential Fatty Acids. 164. 102229–102229. 11 indexed citations

Rohwer, Nadine, et al.. (2019). Omega-3 fatty acid supplementation – A possible dietary adjunct to enhance immune checkpoint inhibition therapy in cancer?. 4(1-2). 83–88. 2 indexed citations

10.

Schmöcker, Christoph, Ingrid W. Zhang, Ursula Kassner, et al.. (2018). Effect of Omega-3 Fatty Acid Supplementation on Oxylipins in a Routine Clinical Setting. International Journal of Molecular Sciences. 19(1). 180–180. 23 indexed citations

11.

Schunck, Wolf‐Hagen, Anne Konkel, Robert Fischer, & Karsten H. Weylandt. (2017). Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases. Pharmacology & Therapeutics. 183. 177–204. 157 indexed citations

12.

Schmöcker, Christoph, et al.. (2016). A lipidomic analysis approach in patients undergoing lipoprotein apheresis. Atherosclerosis. 249. 30–35. 5 indexed citations

13.

Weylandt, Karsten H., Simona Serini, Yong Q. Chen, et al.. (2015). Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence. BioMed Research International. 2015. 1–24. 96 indexed citations

14.

Cittadini, Achille, Gabriella Calviello, Hui‐Min Su, & Karsten H. Weylandt. (2013). -3 PUFAs in the Prevention and Cure of Inflammatory, Degenerative, and Neoplastic Diseases. BioMed Research International. 2013. 1–2. 3 indexed citations

15.

Habbel, Piet, Karsten H. Weylandt, Johannes Nowak, et al.. (2009). Docosahexaenoic acid suppresses arachidonic acid-induced proliferation of LS-174T human colon carcinoma cells. World Journal of Gastroenterology. 15(9). 1079–1079. 31 indexed citations

16.

Kang, Jing X. & Karsten H. Weylandt. (2008). Modulation of Inflammatory Cytokines by Omega-3 Fatty Acids. Sub-cellular biochemistry. 49. 133–143. 144 indexed citations

17.

Weylandt, Karsten H., Joanna S. Amey, David Carmena, et al.. (2007). ClC-3 expression enhances etoposide resistance by increasing acidification of the late endocytic compartment. Molecular Cancer Therapeutics. 6(3). 979–986. 51 indexed citations

18.

Weylandt, Karsten H., Jing X. Kang, Bertram Wiedenmann, & Daniel C. Baumgart. (2007). Lipoxins and resolvins in inflammatory bowel disease. Inflammatory Bowel Diseases. 13(6). 797–799. 50 indexed citations

19.

Hudert, Christian, Karsten H. Weylandt, Yan Lü, et al.. (2006). Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proceedings of the National Academy of Sciences. 103(30). 11276–11281. 315 indexed citations

20.

Okkenhaug, Hanneke, Karsten H. Weylandt, David Carmena, et al.. (2006). The human ClC‐4 protein, a member of the CLC chloride channel/transporter family, is localized to the endoplasmic reticulum by its N‐terminus. The FASEB Journal. 20(13). 2390–2392. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact